Wilson Sonsini Goodrich & Rosati advised Curon Biopharma on the deal. Curon Biopharma, a Shanghai based clinical-stage biopharmaceutical company, acquired exclusive rights to Tenalisib from Rhizen…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now